Summary
Human arterial smooth muscle cells (hASMC) from explants of the inner media of uterine arteries were studied in secondary culture. We had previously found that these cells depend on exogenous platelet-derived growth factor (PDGF) for proliferation in vitro. Deprivation of the serum mitogen(s) by culture in plasma-derived serum or bovine serum albumin (BSA) caused a true growth arrest that was reversible upon reexposure to the mitogen(s). When added to serum-containing medium, heparin caused a reversible growth arrest which could be competed for by increasing concentrations of serum. In the current study we used a set of smooth muscle-specific actin and myosin, antibodies to study the expression of contractile proteins in stress fibers under indirect immunofluorescence on hASMC in culture. Even in sparse culture, grwoth-arrested hASMC expressed stress fibers containing these actin and myosin epitopes. This was true irrespective of whether growth arrest was achieved by culture in media containing only BSA or a combination of heparin and whole blood serum. hASMC proliferating in whole blood serum in sparse culture did not express such strees fibers, as judged by immunofluorescent staining. This was true also for cells that were restimulated to proliferate in serum after a growth arrest. Utilizing a monoclonal antibody against a nuclear antigen expressed in proliferating human cells, we were able to demonstrate an inverse relationship between the expression of this antigen and the SMC-specific contractile proteins, respectively. Under these culture conditions, the reversible transition between defifferentiated and differentiated hASMC was almost complete and terminated about 1 wk after the change in culture condition. We conclude that hASMC in vitro respond, to exogenous PDGF by proliferation and dedifferetiation as a single population of cells. We also conclude that this modulation is reversible, because the cells become uniformly quiescent and differentiated when the mitogenic stimulus is blocked or removed.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Barja, F.; Coughlin, C.; Berlin, D., et al. Actin isoform synthesis and mRNA levels in quiescent and proliferating rat aortic smooth muscle cells in vivo and in vitro. Lab. Invest. 55:226–233; 1986.
Castellot, J.; Favreau, L. V.; Karnovsky, M. J., et al. Inhibition of vascular smooth muscle cell growth by endothelial cellderived heparin. Possible role of endoglycosidase. J. Biol. Chem. 257:11256–11260; 1982.
Chamley, J. H.; Campbell, G. R.; Burnstock, G. Dedifferentiation, redifferentiation and bundle formation of smooth muscle cells in tissue culture: the influence of cell number and nerve fibres. J. Embryol. Exp. Morphol. 32:297–323; 1974.
Chamley-Campbell, J. H.; Campbell, G. R. What controls smooth muscle phenotype? Atherosclerosis 40:347–357; 1981.
Fager, G.; Hansson, G. K.; Ottosson, P., et al. Human arterial smooth muscle cells in culture. Effects of platelet-derived growth factor and heparin on growth in vitro. Exp. Cell Res. 176:319–335; 1988.
Franke, W. W.; Schmid, E.; Vandekerckhove, J., et al. A permanently proliferating rat vascular smooth muscle cell with maintained expression of smooth muscle characteristics, including actin of the vascular smooth muscle type. J. Cell Biol. 87:594–600; 1980.
Fritze, L. M.; Reilly, C. F.; Rosenberg, R. D. An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells. J. Cell Biol. 100:1041–1049; 1985.
Gerdes, J.; Lemke, H.; Baisch, H., et al. Cell cycle analysis of a cell proliferation-associated antigen defined by the monoclonal antibody Ki-67. J. Immunol. 133:1710–1715; 1984.
Gown, A. M.; Vogel, A. M.; Gordon, D., et al. A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes. J. Cell Biol. 100:807–813; 1985.
Gown, A. M.; Tsukada, T.; Ross, R. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am. J. Pathol. 125:191–207; 1986.
Grotendorst, G. R.; Seppä H. E. J.; Kleinman, H. K., et al. Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. Proc. Natl. Acad. Sci. USA 78:3669–3672; 1981.
Grotendorst, G. R.; Chang, T.; Seppä, H. E. J., et al. Plateletderived growth factor is a chemoattractant for vascular smooth muscle cells. J. Cell. Physiol. 113:261–266; 1982.
Johnson, G. D.; Davidson, R. S.; McNamee, K. C., et al. Fading of immunfluorescence during microscopy: a study of the phenomenon and its remedy. J. Immunol. Methods 55:231–242; 1982.
Jonasson, L.; Holm, J.; Skalli, O., et al. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6:131–138; 1986.
Kocher, O.; Gabbiani, G. Cytoskeletal features of normal and atheromatous human arterial smooth muscle cells. Hum. Pathol. 17:875–880; 1986.
Kocher, O.; Gabbiani, G. Expression of actin mRNA in rat aortic smooth muscle cells during development, experimental intimal thickening, and culture. Differentiation 32:245–251; 1986.
Kocher, O.; Gabbiani, G. Analysis of α-smooth-muscle actin mRNA expression in rat aortic smooth-muscle cells using a specific cDNA probe. Differentiation 34:201–209; 1987.
Larson, D. M.; Fujiwara, K.; Alexander, R. W., et al. Myosin in cultured vascular smooth mucle cells: immunofluorescence and immunochemical studies of alterations in antigenic expression. J. Cell Biol. 99:1582–1589; 1984.
Larsson, D. M.; Fujiwara, K.; Alexander, R. W., et al. Heterogeneity of myosin antigenic expression in vascular smooth muscle in vivo. Lab. Invest. 50:401–407; 1984.
Majack, R. A.; Clowes, A. W. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J. Cell. Physiol. 118:253–256; 1984.
Mosse, P. R. L.; Campbell, G. R.; Wang, Z. L., et al. Smooth muscle phenotypic expression in human carotid arteries. II. Comparison of cells from diffuse intimal thickenings adjacent to atheromatous plaques with those of the media. Lab. Invest. 53:556–562; 1985.
Orekhov, A. N.; Kosykh, V. A.; Repin, V. S., et al. Cell proliferation in normal and atherosclerotic human aorta. II. Autoradiographic observation on deoxyribonucleic acid synthesis in primary cell culture. Lab. Invest. 48:749–754; 1983.
Owens, G. K.; Loeb, A.; Gordon, D., et al. Expression of smooth muscle-specific isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J. Cell Biol. 102:343–352; 1986.
Ross, R. Atherosclerosis: A problem of the biology of arterial wall cells and their interactions with blood components. Arteriosclerosis 1:293–311; 1981.
Rovner, A. S.; Murphy, R. A.; Owens, G. K. Expression of smooth muscle and nonmuscle myosin heavy chains in cultured vascular smooth muscle cells. J. Biol. Chem. 261:14740–14745; 1986.
Schwartz, S.; Campbell, G. R.; Campbell, J. H. Replication of smooth muscle cells in vascular disease. Circ. Res. 58:427–444; 1986.
Skalli, O.; Ropraz, P.; Trzeciak, A., et al. A monoclonal antibody against α-smooth muscle actin: a new probe, for smooth muscle differentiation. J. Cell Biol. 103:2787–2796; 1986.
Tsukada, T.; Tippens, D.; Gordon, D., et al. HHF 35, a muscleactin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization. Am. J. Pathol. 126:51–60; 1987.
Author information
Authors and Affiliations
Additional information
This study was supported by grants from the Swedish Medical Research Council (Project no. 4531 and 6816), the Swedish Association against Heart and Chest Diseases, the King Gustaf V and Queen Victoria Foundation, the National Institutes of Health, Bethesda, MD (grant HL 29873) and the Swedish National Board for Laboratory Animals.
Rights and permissions
About this article
Cite this article
Fager, G., Hansson, G.K., Gown, A.M. et al. Human arterial smooth muscle cells in culture: Inverse relationship between proliferation and expression of contractile proteins. In Vitro Cell Dev Biol 25, 511–520 (1989). https://doi.org/10.1007/BF02623563
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02623563